BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Alnylam Emerges as Winner in Rare Disease Study Showdown With Ionis

  Alnylam and Sanofi Genzyme presented positive Phase III results of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy at a conference in France.

  November 2, 2017

   · 

  3 min read

   · 

  Mark Terry
• Business

  Cyclacel Pharmaceuticals to Release Third Quarter 2017 Financial Results

  The Company will host a conference call and live webcast at 4:30 p.m. ET on the same day.

  November 2, 2017

   · 

  3 min read
• 

  Business

  Amgen, Novartis Rev Up for New Alzheimer’s Study

  Novartis announced they have expanded their collaboration with the Banner Alzheimer’s Institute to launch a new clinical trial in ALZ’s.

  November 2, 2017

   · 

  2 min read

   · 

  Mark Terry
• Deals

  Shark Tank Billionaire Mark Cuban Invests in Tiny Bay Area Biotech Perlara

  November 2, 2017

   · 

  2 min read

   · 

  Mark Terry